Established: 1976
Size: A4
Frequency: Twice weekly (Wednesday and Friday)
Circulation: 7,941 (2003 ABC Figure) - Paid subscription
Readership: 80,500 +

The leading source of global news in the pharmaceutical industry. Scrip keeps readers abreast of licensing activity, distribution and trade agreements,the actions of companies and associations, and of the policies and practices of governments and their agencies.

• Scrip is the most widely read pharmaceutical publication in Europe
• Scrip is the 2nd most widely read pharmaceutical publication in North America
• Scrip has the industry's largest 100% entirely paid subscription
• Scrip limits ad space per issue and all ads face editorial for maximum exposure
• Scrip is not only thoroughly read by the primary recipient, but routed to as many as EIGHT colleagues
• Scrip, editorially, is the world's gold standard for reporting on the industry
• Scrip with its senior readership is ideal for recruiting highly qualified personnel

Paul Thoroughgood - Sales (Europe & ROW)
Tel: +44 (0)20 7017 6929
Fax: +44 (0)20 7017 6787
paul.thoroughgood@informa.com

Ken May - Display Advertising (North America)
Tel: + 1 212 520 2788 
Fax: + 1 212 262 8234
scripads@pharmabooks.com

Established: 1990
Size: A4
Frequency: Monthly

An international journal providing the latest information on existing and proposed legislative requirements on a country by country basis, including the latest facts and figures on regulatory affairs.

• The perfect reference tool for regulatory affairs professionals
• World-wide readership
• Ideal for specific target marketing - read by the decision makers in regulatory affairs
• Mono & colour advertising available
• A low advertisement to editorial ratio

Steve Day
Advertising Representative
Tel: +44 (0)207 017 6010
Fax: +44 (0)207 017 6705
email: stephen.day@informa.com
Website: www.tandf.co.uk/journals

Established: 1992 - under its former name EPLC
Size: A4
Frequency: Monthly

A monthly newsletter focusing on EC regulatory affairs in the healthcare industry. Bringing readers news and analysis of topical European Regulatory affairs in both the human and veterinary industry.

• A readership of senior executives world-wide
• 100% subscription based, so advertisers reach an information hungry audience
• Easy to read monthly update on regulations and guidelines
• Written commentary by practising lawyers